Loading...

By MBN Staff - Mon, 01/19/2026 - 08:46

Multicare and KalVista partner to expand access to the first oral on-demand treatment for hereditary angioedema (HAE) across Latin America.

Partnership Content

https://mexicobusiness.news/tag/regulatory-affairs

More Health

By MBN Staff - Mon, 11/24/2025 - 12:20

WHO’s GAP-f outlines new steps to expand access to age-appropriate medicines as global demand for pediatric treatments grows.

By Sofía Garduño - Thu, 11/06/2025 - 16:03

Pfizer and Novo Nordisk escalate legal battle over Metsera amid rising competition in the obesity treatment market.

By MBN Staff - Mon, 07/21/2025 - 16:16

Effective July 21, SENER has relocated its official headquarters to Insurgentes Ave. 20 in Mexico City.

By Sofía Garduño - Fri, 07/11/2025 - 09:08

Rapid changes and uncertainty call for an experienced hand to address Mexico’s regulatory challenges, says Josúe Garza, Managing Director, IPS.

By Sofía Garduño - Thu, 07/10/2025 - 12:39

Mexico announces over MX$10 billion in pharmaceutical investment and works with India to deepen collaboration in health.

By MBN Staff - Wed, 07/02/2025 - 10:14

ESTEVE acquires global rights to Caprelsa, expanding access to a rare thyroid cancer treatment in Mexico and over 50 countries.

By Sofía Garduño - Fri, 05/30/2025 - 11:27

Mexico is unique from a regulatory standpoint, and that uniqueness is one of its key challenges, says Freyr Solutions’ Claudia Díaz.

By Sofía Garduño - Thu, 03/27/2025 - 10:00

This week, WHO and UNAIDS warn of tuberculosis and HIV setbacks, while COFEPRIS fast-tracks clinical trials. This is The Week in Health!

By MBN Staff - Mon, 03/24/2025 - 17:37

COFEPRIS will recognize foreign regulatory evaluations to expedite clinical research, aligning with global standards.